Scienture Holdings, Inc. (SCNX)
SCNX Stock Price Chart
Explore Scienture Holdings, Inc. interactive price chart. Choose custom timeframes to analyze SCNX price movements and trends.
SCNX Company Profile
Discover essential business fundamentals and corporate details for Scienture Holdings, Inc. (SCNX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
6 Feb 2014
Employees
14.00
Website
https://www.trxadehealth.comCEO
Shankar Hariharan
Description
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
SCNX Financial Timeline
Browse a chronological timeline of Scienture Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 5 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at -$0.48 .
Earnings released on 12 May 2025
EPS came in at -$0.33 , while revenue for the quarter reached $10.26K .
Earnings released on 26 Mar 2025
EPS came in at -$0.82 , while revenue for the quarter reached $53.08K , missing expectations by -97.91%.
Earnings released on 6 Nov 2024
EPS came in at -$1.34 falling short of the estimated -$0.15 by -793.33%, while revenue for the quarter reached $64.86K , missing expectations by -97.38%.
Earnings released on 9 Aug 2024
EPS came in at -$1.04 falling short of the estimated -$0.15 by -593.33%, while revenue for the quarter reached $18.70K , missing expectations by -99.18%.
Dividend declared on 8 Jul 2024
A dividend of $1.50 per share was announced, adjusted to $1.50. The dividend was paid on 24 Jul 2024.
Earnings released on 26 Jun 2024
EPS came in at -$6.40 falling short of the estimated -$0.15 by -4.17K%.
Earnings released on 31 Dec 2023
EPS came in at -$4.93 , while revenue for the quarter reached $2.35M .
Earnings released on 30 Sept 2023
EPS came in at -$1.49 falling short of the estimated -$0.15 by -894.43%, while revenue for the quarter reached $392.29K , missing expectations by -82.79%.
Earnings released on 30 Jun 2023
EPS came in at -$2.90 falling short of the estimated -$0.75 by -286.55%, while revenue for the quarter reached $366.53K , missing expectations by -82.21%.
Stock split effective on 22 Jun 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at -$1.01 falling short of the estimated -$0.30 by -236.93%, while revenue for the quarter reached $493.32K , missing expectations by -81.43%.
Earnings released on 31 Dec 2022
EPS came in at -$1.50 falling short of the estimated -$0.90 by -66.40%, while revenue for the quarter reached $2.53M , beating expectations by +0.64%.
Earnings released on 30 Sept 2022
EPS came in at -$0.91 , while revenue for the quarter reached $2.06M .
Earnings released on 30 Jun 2022
EPS came in at -$1.99 falling short of the estimated -$1.73 by -15.19%, while revenue for the quarter reached $3.28M , missing expectations by -0.49%.
Earnings released on 31 Mar 2022
EPS came in at -$1.76 , while revenue for the quarter reached $3.24M .
Earnings released on 31 Dec 2021
EPS came in at -$1.44 , while revenue for the quarter reached $2.39M .
Earnings released on 30 Sept 2021
EPS came in at -$2.39 , while revenue for the quarter reached $2.55M .
Earnings released on 30 Jun 2021
EPS came in at -$4.76 , while revenue for the quarter reached $1.90M .
Earnings released on 31 Mar 2021
EPS came in at -$1.21 , while revenue for the quarter reached $3.05M .
Earnings released on 31 Dec 2020
EPS came in at -$4.39 , while revenue for the quarter reached $1.99M .
Earnings released on 30 Sept 2020
EPS came in at $0.26 , while revenue for the quarter reached $6.33M .
SCNX Stock Performance
Access detailed SCNX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.